Company profile for Allergan Aesthetics

PharmaCompass
Related CompaniesRelated Companies

About

We create the products and technologies that drive the advancement of aesthetic medicine. At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. With our own research and development team focused on driving innovation in aesthetics, we’re committed to providing the most comprehensive science-based product offerings available.

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Irvine, California
Telephone
Telephone
+1 800 377-7790
youtube
YouTube
Twitter
Twitter
Contact Info
Others

Events

Webinars & Exhibitions

Default Event

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content read-more

Explore the latest content creation from this company

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/allergan-aesthetics-to-launch-three-new-state-of-the-art-training-centers-in-the-us-expanding-access-to-high-quality-aesthetics-training-302374118.html

PR NEWSWIRE
12 Feb 2025

https://www.prnewswire.com/news-releases/allergan-aesthetics-the-american-society-of-plastic-surgeons-asps-and-the-aesthetic-society-release-two-new-engaging-limitless-videos-celebrating-women-surgeons-302368870.html

PR NEWSWIRE
05 Feb 2025

https://www.prnewswire.com/news-releases/allergan-aesthetics-unveils-new-aa-signature-program-and-immersive-booth-at-imcas-world-congress-2025-302359301.html

PR NEWSWIRE
24 Jan 2025

https://www.prnewswire.com/news-releases/allergan-aesthetics-offers-free-business-education-courses-online-to-support-growing-practices-with-allergan-aesthetics-products-302307919.html

PR NEWSWIRE
18 Nov 2024

https://news.abbvie.com/2024-10-29-SkinSpirit-joins-Allergan-Aesthetics-in-Supporting-Girls-Inc-and-Empowering-the-New-Generation-of-Women-in-STEM#:~:text=IRVINE%2C%20Calif.%2C%20Oct.,explore%20career%20paths%20in%20STEM

PRESS RELEASE
30 Oct 2024

https://www.prnewswire.com/news-releases/skinspirit-joins-allergan-aesthetics-in-supporting-girls-inc-and-empowering-the-new-generation-of-women-in-stem-302289495.html

PR NEWSWIRE
29 Oct 2024

Drugs in Development

read-more
read-more

Details:

AGN-151586 (trenibotulinumtoxinE) is a first-in-class, short-acting neurotoxin, which is investigated for the treatment of Glabellar Lines. If approved, BoNT/E will be the first neurotoxin of its kind available to patients.


Lead Product(s): TrenibotulinumtoxinE

Therapeutic Area: Dermatology Brand Name: AGN-151586

Study Phase: Phase IIIProduct Type: Large molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 24, 2023

Abbvie CB

01

Bacteriophage Summit
Not Confirmed

Lead Product(s) : TrenibotulinumtoxinE

Therapeutic Area : Dermatology

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : Not Applicable

Deal Size : Not Applicable

Deal Type : Not Applicable

Details : AGN-151586 (trenibotulinumtoxinE) is a first-in-class, short-acting neurotoxin, which is investigated for the treatment of Glabellar Lines. If approved, BoNT/E will be the first neurotoxin of its kind available to patients.

Product Name : AGN-151586

Product Type : Large molecule

Upfront Cash : Not Applicable

October 24, 2023

Abbvie CB

Details:

Botox Cosmetic (onabotulinumtoxinA) is first and only product of its kind that is approved by U.S. FDA to treat three areas, temporarily improving the appearance of moderate to severe forehead lines, glabellar lines and crow's feet in adults.


Lead Product(s): OnabotulinumtoxinA

Therapeutic Area: Dermatology Brand Name: Botox Cosmetic

Study Phase: Phase IIIProduct Type: Large molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 18, 2023

Abbvie CB

02

Bacteriophage Summit
Not Confirmed

Lead Product(s) : OnabotulinumtoxinA

Therapeutic Area : Dermatology

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : Not Applicable

Deal Size : Not Applicable

Deal Type : Not Applicable

Details : Botox Cosmetic (onabotulinumtoxinA) is first and only product of its kind that is approved by U.S. FDA to treat three areas, temporarily improving the appearance of moderate to severe forehead lines, glabellar lines and crow's feet in adults.

Product Name : Botox Cosmetic

Product Type : Large molecule

Upfront Cash : Not Applicable

September 18, 2023

Abbvie CB

Details:

Juvederm Voluma™ XC (hyaluronic acid) is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face in adults over the age of 21.


Lead Product(s): Hyaluronic Acid

Therapeutic Area: Dermatology Brand Name: Juvederm Volux XC

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable January 18, 2023

Abbvie CB

03

Bacteriophage Summit
Not Confirmed

Details : Juvederm Voluma™ XC (hyaluronic acid) is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face in adults over the age of 21.

Product Name : Juvederm Volux XC

Product Type : Small molecule

Upfront Cash : Not Applicable

January 18, 2023

Abbvie CB

Details:

The SkinMedica (coffea arabica) Even & Correct products are hydroquinone-free, well tolerated, and effective on all skin types and for multiple ethnicities. Most SkinMedica® products are intended to meet the FDA's definition of a cosmetic product.


Lead Product(s): Coffea Arabica,Caffeine,Hydrolyzed Rice Protein

Therapeutic Area: Dermatology Brand Name: SkinMedica

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable January 17, 2023

Abbvie CB

04

Bacteriophage Summit
Not Confirmed

Lead Product(s) : Coffea Arabica,Caffeine,Hydrolyzed Rice Protein

Therapeutic Area : Dermatology

Highest Development Status : Approved

Partner/Sponsor/Collaborator : Not Applicable

Deal Size : Not Applicable

Deal Type : Not Applicable

Details : The SkinMedica (coffea arabica) Even & Correct products are hydroquinone-free, well tolerated, and effective on all skin types and for multiple ethnicities. Most SkinMedica® products are intended to meet the FDA's definition of a cosmetic product.

Product Name : SkinMedica

Product Type : Small molecule

Upfront Cash : Not Applicable

January 17, 2023

Abbvie CB

Details:

BOTOX (OnabotulinumtoxinA) Cosmetic is a prescription medicine that is injected into muscles and used to temporarily improve the look of moderate to severe forehead lines, crow's feet lines, and frown lines between the eyebrows in adults.


Lead Product(s): OnabotulinumtoxinA

Therapeutic Area: Dermatology Brand Name: Botox

Study Phase: ApprovedProduct Type: Large molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable November 02, 2022

Abbvie CB

05

Bacteriophage Summit
Not Confirmed

Lead Product(s) : OnabotulinumtoxinA

Therapeutic Area : Dermatology

Highest Development Status : Approved

Partner/Sponsor/Collaborator : Not Applicable

Deal Size : Not Applicable

Deal Type : Not Applicable

Details : BOTOX (OnabotulinumtoxinA) Cosmetic is a prescription medicine that is injected into muscles and used to temporarily improve the look of moderate to severe forehead lines, crow's feet lines, and frown lines between the eyebrows in adults.

Product Name : Botox

Product Type : Large molecule

Upfront Cash : Not Applicable

November 02, 2022

Abbvie CB

Details:

BOTOX® Cosmetic (onabotulinumtoxinA) is first and only product of its kind that is approved by U.S. FDA to treat three areas, temporarily improving the appearance of moderate to severe forehead lines, glabellar lines and crow's feet in adults.


Lead Product(s): OnabotulinumtoxinA

Therapeutic Area: Dermatology Brand Name: Botox

Study Phase: ApprovedProduct Type: Large molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 13, 2022

Abbvie CB

06

Bacteriophage Summit
Not Confirmed

Lead Product(s) : OnabotulinumtoxinA

Therapeutic Area : Dermatology

Highest Development Status : Approved

Partner/Sponsor/Collaborator : Not Applicable

Deal Size : Not Applicable

Deal Type : Not Applicable

Details : BOTOX® Cosmetic (onabotulinumtoxinA) is first and only product of its kind that is approved by U.S. FDA to treat three areas, temporarily improving the appearance of moderate to severe forehead lines, glabellar lines and crow's feet in adults.

Product Name : Botox

Product Type : Large molecule

Upfront Cash : Not Applicable

September 13, 2022

Abbvie CB

Details:

Data analyses of onabotulinumtoxinA (BOTOX®) in adult patients with chronic migraine, cervical dystonia, overactive bladder, spasticity, and pediatric patients with neurogenic detrusor overactivity provide further insights on real-world utilization and long-term use.


Lead Product(s): OnabotulinumtoxinA

Therapeutic Area: Neurology Brand Name: Botox

Study Phase: ApprovedProduct Type: Large molecule

Recipient: AbbVie Inc

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 25, 2022

Abbvie CB

07

Bacteriophage Summit
Not Confirmed

Details : Data analyses of onabotulinumtoxinA (BOTOX®) in adult patients with chronic migraine, cervical dystonia, overactive bladder, spasticity, and pediatric patients with neurogenic detrusor overactivity provide further insights on real-world utilization and ...

Product Name : Botox

Product Type : Large molecule

Upfront Cash : Not Applicable

July 25, 2022

Abbvie CB

Details:

VUITY, an optimized formulation of pilocarpine, established eye care therapeutic, specifically designed to treat age-related blurry near vision. It is delivered with proprietary pHast™ technology, which allows VUITY to rapidly adjust to physiologic pH of the tear film.


Lead Product(s): Pilocarpine Hydrochloride

Therapeutic Area: Ophthalmology Brand Name: Vuity

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 28, 2022

Abbvie CB

08

Bacteriophage Summit
Not Confirmed

Details : VUITY, an optimized formulation of pilocarpine, established eye care therapeutic, specifically designed to treat age-related blurry near vision. It is delivered with proprietary pHast™ technology, which allows VUITY to rapidly adjust to physiologic pH ...

Product Name : Vuity

Product Type : Small molecule

Upfront Cash : Not Applicable

April 28, 2022

Abbvie CB

Details:

VUITY is an optimized formulation of pilocarpine, an established eye care therapeutic, specifically designed to treat age-related blurry near vision. It is delivered with proprietary pHas technology, which allows VUITY to rapidly adjust to physiologic pH of the tear film.


Lead Product(s): Pilocarpine Hydrochloride

Therapeutic Area: Ophthalmology Brand Name: Vuity

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 19, 2022

Abbvie CB

09

Bacteriophage Summit
Not Confirmed

Details : VUITY is an optimized formulation of pilocarpine, an established eye care therapeutic, specifically designed to treat age-related blurry near vision. It is delivered with proprietary pHas technology, which allows VUITY to rapidly adjust to physiologic pH...

Product Name : Vuity

Product Type : Small molecule

Upfront Cash : Not Applicable

April 19, 2022

Abbvie CB

Details:

BOTOX Cosmetic (onabotulinumtoxinA), the first and only neurotoxin product approved by U.S.FDA, to temporarily improve the look of moderate to severe lines in three areas; frown lines, crow's feet and forehead lines.


Lead Product(s): OnabotulinumtoxinA

Therapeutic Area: Dermatology Brand Name: Botox

Study Phase: ApprovedProduct Type: Large molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 13, 2022

Abbvie CB

10

Bacteriophage Summit
Not Confirmed

Lead Product(s) : OnabotulinumtoxinA

Therapeutic Area : Dermatology

Highest Development Status : Approved

Partner/Sponsor/Collaborator : Not Applicable

Deal Size : Not Applicable

Deal Type : Not Applicable

Details : BOTOX Cosmetic (onabotulinumtoxinA), the first and only neurotoxin product approved by U.S.FDA, to temporarily improve the look of moderate to severe lines in three areas; frown lines, crow's feet and forehead lines.

Product Name : Botox

Product Type : Large molecule

Upfront Cash : Not Applicable

April 13, 2022

Abbvie CB
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Inspections and registrations

Check the inspections & registration from this company

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty